Cortical β-amyloid burden, neuropsychiatric symptoms, and cognitive status: the Mayo Clinic Study of Aging.


Journal

Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664

Informations de publication

Date de publication:
28 03 2019
Historique:
received: 11 02 2019
accepted: 16 02 2019
entrez: 30 3 2019
pubmed: 30 3 2019
medline: 10 1 2020
Statut: epublish

Résumé

Neuropsychiatric symptoms (NPS) are a risk factor for cognitive impairment and are associated with cortical β-amyloid (Aβ) deposition. We conducted a cross-sectional study derived from the ongoing population-based Mayo Clinic Study of Aging to examine the frequency of NPS among cognitively unimpaired (CU) and mild cognitive impairment (MCI) participants who either have normal (A-) or abnormal (A+) Aβ deposition. We also investigated whether combined presence of MCI and amyloid positivity (MCI/A+) is associated with greater odds of having NPS as compared to CU/A- (defined as reference group). Participants were 1627 CU and MCI individuals aged ≥ 50 years (54% males; median age 73 years). All participants underwent NPS assessment (Neuropsychiatric Inventory Questionnaire (NPI-Q); Beck Depression Inventory II (BDI-II); Beck Anxiety Inventory (BAI)) and

Identifiants

pubmed: 30923322
doi: 10.1038/s41398-019-0456-z
pii: 10.1038/s41398-019-0456-z
pmc: PMC6438979
doi:

Substances chimiques

Amyloid beta-Peptides 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

123

Subventions

Organisme : NIMH NIH HHS
ID : K01 MH068351
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG041851
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG034676
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG016574
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG011378
Pays : United States
Organisme : NIA NIH HHS
ID : K01 AG028573
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG057708
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG006786
Pays : United States

Références

Am J Geriatr Psychiatry. 2013 Jul;21(7):685-95
pubmed: 23567400
Continuum (Minneap Minn). 2016 Apr;22(2 Dementia):404-18
pubmed: 27042901
Int Psychogeriatr. 2018 Feb;30(2):245-251
pubmed: 29198244
Am J Geriatr Psychiatry. 2009 Jun;17(6):493-502
pubmed: 19472439
Int J Geriatr Psychiatry. 2016 Aug;31(8):920-8
pubmed: 26766490
Alzheimers Dement. 2013 Sep;9(5):602-8
pubmed: 23562430
JAMA. 2002 Sep 25;288(12):1475-83
pubmed: 12243634
Am J Psychiatry. 2014 May;171(5):572-81
pubmed: 24700290
Alzheimers Dement. 2017 Mar;13(3):205-216
pubmed: 27697430
J Neurol Neurosurg Psychiatry. 2014 Apr;85(4):449-55
pubmed: 24133289
Arch Gen Psychiatry. 2008 Oct;65(10):1193-8
pubmed: 18838636
J Intern Med. 2004 Sep;256(3):183-94
pubmed: 15324362
Am J Psychiatry. 2018 Jun 1;175(6):530-537
pubmed: 29325447
J Geriatr Psychiatry Neurol. 2016 May;29(3):149-59
pubmed: 26400248
Alzheimers Dement. 2011 May;7(3):270-9
pubmed: 21514249
J Clin Exp Neuropsychol. 1998 Apr;20(2):194-200
pubmed: 9777473
Neurology. 2015 Mar 3;84(9):935-43
pubmed: 25653291
Am J Geriatr Psychiatry. 2016 Dec;24(12):1191-1195
pubmed: 27742526
Neuroepidemiology. 2008;30(1):58-69
pubmed: 18259084
Arch Neurol. 1991 Jul;48(7):725-8
pubmed: 1859300
Alzheimer Dis Assoc Disord. 2008 Jul-Sep;22(3):261-8
pubmed: 18580591
J Alzheimers Dis. 2017;56(3):929-938
pubmed: 28059789
J Nucl Med. 2009 Jun;50(6):878-86
pubmed: 19443597
J Alzheimers Dis. 2012;31(2):411-20
pubmed: 22571979
J Neuropsychiatry Clin Neurosci. 2013 Fall;25(4):302-7
pubmed: 24247857
Dement Geriatr Cogn Disord. 2007;24(4):253-9
pubmed: 17700021
Am J Geriatr Psychiatry. 2017 Jul;25(7):694-696
pubmed: 28392189
J Intern Med. 2004 Sep;256(3):240-6
pubmed: 15324367
Brain. 2015 May;138(Pt 5):1370-81
pubmed: 25805643
Neurology. 1993 Nov;43(11):2412-4
pubmed: 8232972
J Neuropsychiatry Clin Neurosci. 2000 Spring;12(2):233-9
pubmed: 11001602
J Alzheimers Dis. 2015;49(2):387-98
pubmed: 26484900

Auteurs

Janina Krell-Roesch (J)

Translational Neuroscience and Aging Laboratory, Mayo Clinic, Scottsdale, AZ, USA.
Institute of Sports and Sports Science, Karlsruhe Institute of Technology, Karlsruhe, Germany.

Maria Vassilaki (M)

Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.

Michelle M Mielke (MM)

Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Department of Neurology, Mayo Clinic, Rochester, MN, USA.

Walter K Kremers (WK)

Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.

Val J Lowe (VJ)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.

Prashanthi Vemuri (P)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.

Mary M Machulda (MM)

Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.

Teresa J Christianson (TJ)

Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.

Jeremy A Syrjanen (JA)

Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.

Gorazd B Stokin (GB)

International Clinical Research Center/St. Anne Hospital, Brno, Czech Republic.

Lesley M Butler (LM)

F. Hoffmann-La Roche Ltd, Basel, Switzerland.

Martin Traber (M)

F. Hoffmann-La Roche Ltd, Basel, Switzerland.

Clifford R Jack (CR)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.

David S Knopman (DS)

Department of Neurology, Mayo Clinic, Rochester, MN, USA.

Rosebud O Roberts (RO)

Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Department of Neurology, Mayo Clinic, Rochester, MN, USA.

Ronald C Petersen (RC)

Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Department of Neurology, Mayo Clinic, Rochester, MN, USA.

Yonas E Geda (YE)

Translational Neuroscience and Aging Laboratory, Mayo Clinic, Scottsdale, AZ, USA. geda.yonas@mayo.edu.
Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. geda.yonas@mayo.edu.
Department of Psychiatry and Psychology, Mayo Clinic, Scottsdale, AZ, USA. geda.yonas@mayo.edu.
Department of Neurology, Mayo Clinic, Scottsdale, AZ, USA. geda.yonas@mayo.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH